Akeso Biomedical
Waltham, US · Founded 2014 · Delaware corporation
Founders & leadership
MK
Mark KiddExecutive
SW
Simon WilliamsinExecutive
Board
BP
Bernard PrusaczykBoard director
RC
Robert Calvin GoforthBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 7 of 8 rounds · 2014–2023
▶$25KraisedJun 2023 · 2 investors · OtherRule 506(b)
▶$25KraisedJun 2023 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Greg W LeeDirector
- Kevin OhashiDirector
- Simon WilliamsExecutive Officer, Director
- Scott RothDirector
- Robert Calvin GoforthDirector
- Anthony J SinskeyDirector
- Offering amount
- $200K
- Amount sold
- $25K
- Minimum investment
- $5K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$573.9KraisedFeb 2021 · 30 investors · OtherRule 506(b)
▶$573.9KraisedFeb 2021 · 30 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kevin OhashiDirector
- Scott RothDirector
- Simon WilliamsExecutive Officer, Director
- Greg LeeDirector
- Anthony SinskeyDirector
- Robert Calvin GoforthDirector
- Offering amount
- $1M
- Amount sold
- $573.9K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$597.3KraisedNov 2019 · 20 investors · OtherRule 506(b)
▶$597.3KraisedNov 2019 · 20 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert Calvin GoforthDirector
- Greg W. LeeDirector
- Simon WilliamsExecutive Officer, Director
- Anthony SinskeyDirector
- Scott RothDirector
- Kevin OhashiDirector
- Offering amount
- $3M
- Amount sold
- $597.3K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$981.7KraisedDec 2018 · 51 investors · OtherRule 506(b)
▶$981.7KraisedDec 2018 · 51 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SinskeyDirector
- Kevin OhashiDirector
- Scott RothDirector
- Mark WagstaffExecutive Officer
- R. Calvin GoforthDirector
- Greg W. LeeDirector
- Simon WilliamsExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $981.7K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.5MraisedMar 2017 · 26 investors · OtherRule 506(b)
▶$2.5MraisedMar 2017 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SinskeyDirector
- Robert Calvin GoforthDirector
- Greg W. LeeDirector
- Mark KiddExecutive Officer
- Simon WilliamsExecutive Officer, Director
- Scott RothDirector
- Bernard PrusaczykDirector
- Offering amount
- $5M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$535KraisedJul 2015 · 10 investors · Other Health CareRule 506(b)
▶$535KraisedJul 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark KiddExecutive Officer
- Bernard PrusaczykDirector
- Simon WilliamsExecutive Officer, Director
- Robert Calvin GoforthDirector
- Offering amount
- $1M
- Amount sold
- $535K
- Minimum investment
- $25K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$225KraisedDec 2014 · 9 investors · Other Health CareRule 506(b)
▶$225KraisedDec 2014 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark KiddExecutive Officer
- Simon WilliamsExecutive Officer, Director
- Robert Calvin GoforthDirector
- Bernard PrusaczykDirector
- Offering amount
- $500K
- Amount sold
- $225K
- Minimum investment
- $25K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$250KofferedApr 2014 · OtherRule 506(b)
▶$250KofferedApr 2014 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert Calvin GoforthDirector
- Mark KiddExecutive Officer
- Bernard PrusaczykExecutive Officer, Director
- Simon WilliamsExecutive Officer, Director
- Offering amount
- $250K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
BirdEye6 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Bioworld4 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Akeso Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- How much funding has Akeso Biomedical raised?
- Akeso Biomedical has disclosed $5.5M raised across 7 of its 8 known rounds.
- Where is Akeso Biomedical headquartered?
- Akeso Biomedical is headquartered in Waltham, US.